EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Nexam Chemical Holding AB (NEXAM) fair value: what the stock is really worth

We calculate from audited financials what Nexam Chemical Holding AB is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Basic Materials · SE · ISIN SE0005101003

NC Thin data Sep 13, 2026

Nexam Chemical Holding AB

NEXAM · ST

Weak valuationQuality is weak on top of the rich price.

!Fair value kr 2.17 · Overvalued (−26%)
!Quality 45/100
!Weak Growth (revenue 5y +3.0 %/yr)
!Loss-making · -8.0% net margin (TTM)
Low debt · generates free cash flow
!Mixed vs. peers (5/11)
!Narrow moat 17/100
!Insider activity 40/100
!Evidence only low, so the estimate is less certain
Watch Nexam Chemical Holding AB for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

kr 14.75 kr 2.26 Fair Value kr 2.17 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.

How to read this chart

60‑month range kr 2.26 – kr 14.75 · fair‑value band kr 1.28 – kr 3.86 · the kr 2.95 price screens above the kr 2.17 fair value. Dashed = 300-day average. As of Sep 13, 2026.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Nexam Chemical Holding AB (publ) develops solutions that enhance properties and performance of plastics in Sweden, Europe, and internationally.

Show more

Nexam Chemical Holding AB (publ) develops solutions that enhance properties and performance of plastics in Sweden, Europe, and internationally. The company provides various solutions for polyesters, polyethylene, polyamides, polyimides, polyester foams, as well as produces various functional chemicals, high temperature resins, additive/functional masterbatches, Recolour Plus, and color masterbatches under the NEXAMITE and NEXIMID names; and polymer recycling and reactive recycling solutions. It serves aerospace, electronics, pipes, and engineered foams industries. Nexam Chemical Holding AB (publ) was founded in 2009 and is headquartered in Lomma, Sweden.

Stock analysis

Nexam Chemical Holding AB (NEXAM) currently trades at kr 2.95, while our model-based Fair Value estimate is kr 2.17, implying the stock looks roughly 35.9% overvalued today.

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of kr 2.36 per share, and 0 of the 10 models we run sit above the kr 2.95 price.

Bear case: the Multiples group reads lowest at kr 0.4500, and 10 of the 10 models stay below the price. Evidence for this calculation is low.

Scenario range: kr 1.28 (bear) to kr 3.86 (bull), the price of kr 2.95 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 45/100 (below-average quality), in the Basic Materials sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Nexam Chemical Holding AB reported revenue of 192M SEK in FY2025 versus 219M SEK in FY2021, a compound −3.3%/yr. Reported net income was −16.5M SEK in FY2025.

Key figures

Market cap 355M SEK (≈ $36.7M) · P/S ratio 1.80 · EPS (TTM) kr −0.2200 · Net margin −8.6% · Return on equity −9.7% · Return on assets (EBIT) −4.5% · Operating margin −12.5% · Revenue (TTM) 187M SEK.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 46 out of 100 (low confidence).

What moves the price

The share trades about 29% below its 52-week high and 35% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −47% fair-value upside, at −26%, NEXAM screens cheaper than that median.

Fair Value models

Bear kr 1.28 Fair Value kr 2.17 Bull kr 3.86
Model Each model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence Evidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF kr 1.50 kr 2.18 kr 4.24 72
Growth DCF kr 1.40 kr 2.42 kr 4.03 72
5Y EBITDA Exit kr 0.7200 kr 1.04 kr 1.67 70
All 10 models by family
DCF Models
FCF DCF kr 1.50 kr 2.18 kr 4.24 72
5Y Revenue Exit kr 1.22 kr 2.06 kr 3.81 65
5Y EBITDA Exit kr 0.7200 kr 1.04 kr 1.67 70
10Y Revenue Exit kr 1.28 kr 2.66 kr 3.50 62
10Y EBITDA Exit kr 0.9800 kr 1.67 kr 2.71 63
Multiples
EV/EBITDA kr 0.3400 kr 0.4500 kr 0.5700 67
EV/Revenue kr 1.00 kr 1.43 kr 1.86 53
Asset-Based
NCAV (Graham) kr 0.8200 kr 1.10 kr 1.64 54
Growth DCF
Growth DCF kr 1.40 kr 2.42 kr 4.03 72
Rev-Margin DCF kr 1.34 kr 2.36 kr 4.47 65

Open the full fair value analysis →

Notify me when NEXAM reaches fair value

Put NEXAM on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 45/100

Of which business quality 47 · Market factors (momentum, volatility) 34

Profitability 12
Margins and returns on capital today
Quality Growth 17
Are margins and returns improving?
Cashflow 22
Earnings quality: real cash, not paper profit
Fin. Strength 77
Balance sheet, leverage, solvency risk
Investment 93
Disciplined investing over empire-building
Low Volatility 48
Calm price path (market factor)
Momentum 33
Price trend over the last 3–12 months (market factor)
52W Momentum 21
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality Growth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 30/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−3.7%
Revenue growth 3 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.6%
Revenue growth 5 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.0%
Revenue growth 16 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+71.9%
Profit margin (trend) Operating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−3.1% (2020) → −6.1% (2025)
What shareholders gained per year We only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes This turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+8.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.

NEXAM screens 36% overvalued. Compare with Linde plc →

Compare Nexam Chemical Holding AB with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 706 stocks

Beats the industry median on 4/9 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 45 · Below median
Profitability
Return on assets −3% · Bottom 25%
Net margin (TTM) −8% · Bottom 25%
Operating margin (TTM) 0% · Bottom 25%
Growth and dividend
Revenue growth 11% · Above median
Balance sheet
Debt / equity 0.07× · Below median

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/B 0.22× · Cheapest 25%
P/S (TTM) 0.19× · Cheapest 25%
P/FCF 3.3× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 0
FUTURE (revenue growth)53 · sector 21
PAST (return on equity)0 · sector 23
HEALTH (low debt)96 · sector 95
DIVIDEND (yield)0 · sector 29

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Linde plc LIN $466.22 $425.24 −9%
The Sherwin-Williams Company SHW $323.31 $143.38 −56%
Ecolab Inc ECL $276.18 $96.18 −65%
Air Products and Chemicals, Inc APD $291.43 $122.14 −58%
Nan Ya Plastics Corporation 1303 234.50 TWD 306.47 TWD +31%
Givaudan SA GIVN CHF 3,164 CHF 1,523 −52%
Wanhua Chemical Group 600309 ¥74.50 ¥68.03 −9%
500820 500820 ₹2,470 ₹393.15 −84%
Sika AG SIKA CHF 185.00 CHF 98.89 −47%
Novozymes A/S NSISB kr 427.30 kr 383.60 −10%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Nexam Chemical Holding AB Fair Value". https://www.fairvalue-calculator.com/stock/NEXAM

Frequently asked questions

Is Nexam Chemical Holding AB (NEXAM) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of kr 2.17 versus a price of kr 2.95, about −26% upside (overvalued).
What is the fair value of NEXAM?
Our model-based fair value for Nexam Chemical Holding AB is kr 2.17 (as of Sep 13, 2026), built from audited fundamentals. The current price: kr 2.95.
What is the quality score of NEXAM?
Nexam Chemical Holding AB has a Quality Score of 45/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Nexam Chemical Holding AB (NEXAM)?
Our model-based price target is the fair value of kr 2.17 (as of Sep 13, 2026) from 10 valuation models. Cautious scenario kr 1.28, optimistic scenario kr 3.86. It is a calculation from audited fundamentals, not an analyst target.
What is the Nexam Chemical Holding AB stock forecast for 2026?
Our models put fair value at kr 2.17, about −26% upside versus a price of kr 2.95 (overvalued). Cautious scenario kr 1.28, optimistic scenario kr 3.86. The calculation is refreshed regularly with new filings.
What is the revenue of Nexam Chemical Holding AB (NEXAM)?
Nexam Chemical Holding AB reported trailing-twelve-month revenue of about 187M SEK (latest available figure, as of Sep 13, 2026).
What growth is priced into Nexam Chemical Holding AB (NEXAM)?
For today's price to be fair in a discounted-cash-flow model, Nexam Chemical Holding AB would have to grow free cash flow by +8.1 % per year for five years (discount rate 8.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +3.0 % per year. As of Sep 13, 2026.
What discount rate (WACC) does the fair value of NEXAM use?
Our models discount Nexam Chemical Holding AB at 8.4 %: a base by market capitalisation (nano), damped by beta 0.54, country premium for Sweden. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Nexam Chemical Holding AB that is +8.1 % per year a year over ten years, using the same discount rate (8.4 %) and the same formula as our fair value.
How much growth has Nexam Chemical Holding AB (NEXAM) delivered so far?
Over the past 5 years revenue at Nexam Chemical Holding AB grew +3.0 % a year. The price currently implies +8.1 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Nexam Chemical Holding AB (NEXAM) growing?
The median revenue growth in the sector is +3.2 % a year. That is the yardstick for the growth priced into Nexam Chemical Holding AB (+8.1 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Nexam Chemical Holding AB (NEXAM)?
The free-cash-flow yield on the price is 4.73 %: that much free cash flow Nexam Chemical Holding AB produces per unit of market value. When it exceeds the discount rate of our models (8.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Nexam Chemical Holding AB (NEXAM)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Nexam Chemical Holding AB it is kr 2.17 per share (as of Sep 13, 2026), against a price of kr 2.95. It is the blended result of 10 valuation models (cash flow, earnings, asset, dividend).
Is Nexam Chemical Holding AB stock overvalued or undervalued in 2026?
As of Sep 13, 2026, NEXAM trades above its calculated fair value: price kr 2.95, fair value kr 2.17, a gap of about −26% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NEXAM?
No. The price is what the market pays today (kr 2.95); the fair value is what the company's own numbers justify (kr 2.17). For Nexam Chemical Holding AB the two are kr 0.7800 per share apart. That gap is exactly why we show both numbers side by side.
How much is Nexam Chemical Holding AB worth?
The market values Nexam Chemical Holding AB at about 355M SEK (market capitalisation, as of Sep 13, 2026). Per share that is kr 2.95; our models calculate a fair value of kr 2.17 per share.
What do the bullish and bearish scenarios say about NEXAM?
Our models span a range for Nexam Chemical Holding AB: cautious scenario kr 1.28, base kr 2.17, optimistic kr 3.86 per share (as of Sep 13, 2026, price kr 2.95). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Nexam Chemical Holding AB (NEXAM)?
Balance-sheet figures for Nexam Chemical Holding AB (as of Sep 13, 2026): return on equity −8.0%, debt of 0.07 per unit of equity. They feed the Quality Score of 45/100, which measures business quality independently of the share price.
How far is NEXAM from its 52-week high?
Nexam Chemical Holding AB trades at kr 2.95, about 29% below its 52-week high of kr 4.18 and 35% above the low of kr 2.18 (as of Sep 13, 2026). Distance from the high says nothing about value: that is what the fair value of kr 2.17 is for.
Which stocks are comparable to Nexam Chemical Holding AB?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Nexam Chemical Holding AB stock attractive at the current price?
The data as of Sep 13, 2026: price kr 2.95, calculated fair value kr 2.17 (−26%), Quality Score 45/100, from 10 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NEXAM calculated?
We run Nexam Chemical Holding AB through 10 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 2.17, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.8 % above its aggregate fair value. Nexam Chemical Holding AB itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What should I pay attention to with Nexam Chemical Holding AB right now?
The model range is unusually wide (kr 1.28 to kr 3.86). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid but not exceptional quality (45/100) and above fair value, neither a clear bargain nor a standout compounder. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Nexam Chemical Holding AB

How large is the market capitalisation of Nexam Chemical Holding AB (NEXAM)?
The market capitalisation of Nexam Chemical Holding AB is 355M SEK (≈ $36.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Nexam Chemical Holding AB (NEXAM)?
The price-to-sales ratio of Nexam Chemical Holding AB is 1.80 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Nexam Chemical Holding AB (NEXAM)?
Earnings per share at Nexam Chemical Holding AB are kr −0.2200. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Nexam Chemical Holding AB (NEXAM)?
The net margin of Nexam Chemical Holding AB is −8.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Nexam Chemical Holding AB (NEXAM)?
The return on equity (ROE) of Nexam Chemical Holding AB is −9.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Nexam Chemical Holding AB (NEXAM)?
On an EBIT basis the return on assets of Nexam Chemical Holding AB is −4.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Nexam Chemical Holding AB (NEXAM)?
The operating margin of Nexam Chemical Holding AB is −12.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Nexam Chemical Holding AB (NEXAM)?
Revenue at Nexam Chemical Holding AB is growing −11.0% versus a year earlier (3y avg −4.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net debt does Nexam Chemical Holding AB (NEXAM) carry?
The net debt of Nexam Chemical Holding AB is 16.1M SEK (fiscal year 2025, ≈ 1.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Nexam Chemical Holding AB in the live analysis

One click puts Nexam Chemical Holding AB on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.